Literature DB >> 26238643

Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Nirupama Putcha1, M Bradley Drummond1, Robert A Wise1, Nadia N Hansel1.   

Abstract

Comorbidities impact a large proportion of patients with chronic obstructive pulmonary disease (COPD), with over 80% of patients with COPD estimated to have at least one comorbid chronic condition. Guidelines for the treatment of COPD are just now incorporating comorbidities to their management recommendations of COPD, and it is becoming increasingly clear that multimorbidity as well as specific comorbidities have strong associations with mortality and clinical outcomes in COPD, including dyspnea, exercise capacity, quality of life, healthcare utilization, and exacerbation risk. Appropriately, there has been an increased focus upon describing the burden of comorbidity in the COPD population and incorporating this information into existing efforts to better understand the clinical and phenotypic heterogeneity of this group. In this article, we summarize existing knowledge about comorbidity burden and specific comorbidities in COPD, focusing on prevalence estimates, association with outcomes, and existing knowledge about treatment strategies. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26238643      PMCID: PMC5004772          DOI: 10.1055/s-0035-1556063

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  217 in total

1.  The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study.

Authors:  C-H Li; W-C Chen; W-C Liao; C-Y Tu; C-L Lin; F-C Sung; C-H Chen; W-H Hsu
Journal:  QJM       Date:  2014-07-14

2.  Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study.

Authors:  Elif Küpeli; Gaye Ulubay; Sevinc Sarinc Ulasli; Tugce Sahin; Zeynep Erayman; Alptekin Gürsoy
Journal:  Endocrine       Date:  2010-06-09       Impact factor: 3.633

3.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

4.  Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation.

Authors:  Ben Noteboom; Sue Jenkins; Andrew Maiorana; Nola Cecins; Cindy Ng; Kylie Hill
Journal:  J Cardiopulm Rehabil Prev       Date:  2014 Jan-Feb       Impact factor: 2.081

5.  Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome.

Authors:  Fadia T Shaya; Pei-Jung Lin; Mohammad H Aljawadi; Steven M Scharf
Journal:  Sleep Breath       Date:  2009-05-30       Impact factor: 2.816

6.  The influence of hospitalizations due to exacerbations or spontaneous pneumothoraxes on the quality of life, mental function and symptoms of depression and anxiety in patients with COPD or asthma.

Authors:  Marek Filipowski; Andrzej Bozek; Renata Kozlowska; Damian Czyżewski; Jerzy Jarzab
Journal:  J Asthma       Date:  2013-12-04       Impact factor: 2.515

7.  Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

Authors:  Nichola S Gale; James M Duckers; Stephanie Enright; John R Cockcroft; Dennis J Shale; Charlotte E Bolton
Journal:  BMC Pulm Med       Date:  2011-04-21       Impact factor: 3.317

8.  Impact of COPD exacerbations on osteoporosis assessed by chest CT scan.

Authors:  Hirofumi Kiyokawa; Shigeo Muro; Tsuyoshi Oguma; Susumu Sato; Naoya Tanabe; Tamaki Takahashi; Megumi Kudo; Daisuke Kinose; Hiroshi Kondoh; Takeshi Kubo; Yuma Hoshino; Emiko Ogawa; Toyohiro Hirai; Michiaki Mishima
Journal:  COPD       Date:  2012-02-23       Impact factor: 2.409

9.  Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron.

Authors:  Donald S Silverberg; Ram Mor; Melanie Tia Weu; Doron Schwartz; Idit F Schwartz; Gil Chernin
Journal:  BMC Pulm Med       Date:  2014-02-24       Impact factor: 3.317

10.  Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study.

Authors:  Jinhee Kim; Jin Hwa Lee; Yuri Kim; Kyungjoo Kim; Yeon-Mok Oh; Kwang Ha Yoo; Chin Kook Rhee; Hyoung Kyu Yoon; Young Sam Kim; Yong Bum Park; Sei Won Lee; Sang Do Lee
Journal:  BMC Pulm Med       Date:  2013-08-09       Impact factor: 3.317

View more
  59 in total

1.  Positive Airway Pressure Therapies and Hospitalization in Chronic Obstructive Pulmonary Disease.

Authors:  Monica M Vasquez; Leslie A McClure; Duane L Sherrill; Sanjay R Patel; Jerry Krishnan; Stefano Guerra; Sairam Parthasarathy
Journal:  Am J Med       Date:  2017-01-13       Impact factor: 4.965

2.  Overdiagnosis of COPD: precise definitions and proposals for improvement.

Authors:  Alberto Fernández-Villar; Joan B Soriano; José Luis López-Campos
Journal:  Br J Gen Pract       Date:  2017-04       Impact factor: 5.386

3.  Comorbidity, chronic obstructive pulmonary disease, and acute cardiovascular diseases : The Greek experience.

Authors:  K Papastergiou; K Gourgoulianis
Journal:  Herz       Date:  2017-06-12       Impact factor: 1.443

4.  Mental Illness, Not Obesity Status, is Associated with Food Insecurity Among the Elderly in the Health and Retirement Study.

Authors:  Diana P Brostow; Elise Gunzburger; Lauren M Abbate; Lisa A Brenner; Kali S Thomas
Journal:  J Nutr Gerontol Geriatr       Date:  2019-02-22

5.  Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients.

Authors:  Selma Aydogan Eroglu; Hakan Gunen; Halil Ibrahim Yakar; Ethem Yildiz; Murat Kavas; Dildar Duman
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

6.  A specific subtype of chronic obstructive pulmonary disease classified by forced vital capacity.

Authors:  Chunlan Chen; Ying He; Qiulin Chen; Dongying Zhang; Yuandi Wang; Yanling Tang; Ying Fang; Nanshan Zhong; Wenhua Jian; Jinping Zheng
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

7.  Fate or coincidence: do COPD and major depression share genetic risk factors?

Authors:  Victoria L Martucci; Bradley Richmond; Lea K Davis; Timothy S Blackwell; Nancy J Cox; David Samuels; Digna Velez Edwards; Melinda C Aldrich
Journal:  Hum Mol Genet       Date:  2021-05-12       Impact factor: 6.150

8.  How different combinations of comorbidities affect healthcare use by elderly patients with obstructive lung disease.

Authors:  Alessandra Buja; Andrea Bardin; Giulia Grotto; Stefania Elvini; Pietro Gallina; Giulia Zumerle; Patrizia Benini; Domenico Scibetta; Vincenzo Baldo
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-25       Impact factor: 2.871

9.  Trends in Prevalence and Outcomes of Cannabis Use Among Chronic Obstructive Pulmonary Disease Hospitalizations: A Nationwide Population-Based Study 2005-2014.

Authors:  Kulothungan Gunasekaran; Dinesh C Voruganti; Mandeep Singh Rahi; Kalaimani Elango; Sathishkumar Ramalingam; Adiba Geeti; Jeff Kwon
Journal:  Cannabis Cannabinoid Res       Date:  2021-02-15

Review 10.  Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.

Authors:  Felix M Reyes; Manuel Hache-Marliere; Dimitris Karamanis; Cesar G Berto; Rodolfo Estrada; Matthew Langston; George Ntaios; Perminder Gulani; Chirag D Shah; Leonidas Palaiodimos
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.